Local Insights

Alissa Naran and Nicole Smalberger of Adams & Adams explain the latest developments on protecting trademarks in Africa, in the first of a three-part podcast series

IP judgments in Zimbabwe are unusual, says Chris Walters of Spoor & Fisher Jersey. So the recent Supreme Court decision in Cairns Foods v Netrade Marketing is welcome

Jennifer Colantoni of Spoor & Fisher highlights the key features of the new Industrial Property Act in Mauritius, which comes into force in 2022

Danie Dohmen and Russell Bagnall of Adams & Adams, and in-house counsel Natasha Wright, consider the recent trends in pharmaceutical patent litigation in South Africa and discuss how the enforcement environment evolved during the pandemic

Jenny Pienaar and Kareema Shaik of Adams & Adams consider pharmaceutical registration in the larger African markets, dealing with the challenges of registration and the subsequent enforcement of rights

Godfrey Budeli and Jan-Harm Swanepoel of Adams & Adams explain the latest developments in anti-counterfeiting, in the first of a three-part podcast series on IP enforcement of pharma in Africa

Margaret Le Galle of Spoor & Fisher explains why the Plant Variety Protection Act 2021 will bring Nigerian IP law in line with international norms

Masato Iida of Shiga International Patent Office calls for greater clarity in the Japanese patent linkage system in comparing it with US and Chinese practice

Min Son of Hanol IP & Law reports on a ruling by the Supreme Court of Korea that will make it easier to obtain polymorph patents of known chemicals in the country

Min Son of Hanol IP & Law reports on the Korean Supreme Court allowing a grace period to be claimed in a divisional application even if it was not claimed in the parent application

Loc Xuan Le and Duc Anh Tran of T&G Law Firm explain the issues that arise in relation to the assessment process in copyright disputes

Sukontip Jitmongkolthong and Saithong Rattana of Tilleke & Gibbins describe how Laos has improved its framework to enforce IP rights through border measures

Xiaoyan Zhou of Purplevine IP explains how to protect IP in the rapidly developing area of AI medical devices in China, and the risks involved

David Herman of FB Rice explains what steps are involved in interpreting New Zealand’s Patents Act 2013 and summarises several significant rulings that have established precedents in patent law

Roman Brtka of Bird & Bird comments on the Ferrari Front Kit case and explains the practical consequences for manufacturers that want to protect a part of a product independently of the whole product

Susanna Heurung of Maiwald examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs

Cristina Biggi of Bugnion shares her expertise on second medical use patents in Europe, focusing particularly on recent case law from Italy

Selin Sinem Erciyas and Aysel Korkmaz Yatkın of Gün + Partners explain the significance of a ruling in Turkey on the validity of second medical use patents granted by the European Patent Office

Piotr Dynowski and Andrzej Stelmachowski of Bird & Bird conduct a progress report on the Polish intellectual property courts since their introduction in 2020 and take a glimpse into their future

Zeynep Seda Alhas and Dilan Sıla Kayalıca of Gün + Partners consider the Turkish IP office’s ruling on the opposition proceedings initiated by TBL Licensing, the owner of the Timberland trademark

Owners of German trademarks who rely on their use in Switzerland to protect their mark must change their strategy immediately, as Susanna Heurung of Maiwald explains

Roberta Arantes of Daniel Law looks at how the Brazilian legal landscape has responded to shifts in the concept of branding and its related levels of protection

Kene Gallois and Guilherme Coutinho of Daniel Law explain how the success of the plan will pave the way for Brazil to attract further investment and opportunities

André Oliveira of Daniel Law considers how IP infringement and brand protection has evolved in Brazil amid the pandemic

Carolina Schueler of Daniel Law discusses why naming rights and sponsorship deals could be a profitable two-way partnership that may last for decades

Jaime Rodríguez of Olivares explores how Mexican lawmakers have attempted to strengthen trademark protection in the digital environment

Rafael Salomão Romano and Samantha Salim of Daniel Law outline how the instructions will improve transparency and accountability in the Brazilian pharmaceutical patent scene

It is important not to forget that the Civil Code states that debtors respond to the fulfilment of their obligations with their assets, except for all those assets considered by law as inalienable or which cannot be seized.

Masato Iida of Shiga International Patent Office calls for greater clarity in the Japanese patent linkage system in comparing it with US and Chinese practice

Join Ude Lu, the chief IP counsel (US) of Purplevine IP, Helen Zhang, the litigation manager of Purplevine IP in Beijing, and Penny Sun, the brand protection manager of ABRO Industry, as they discuss evidence collection for patent enforcement in China and the US virtually with Managing IP on November 9 at 10am (US ET) / 3pm (UK) / 11pm (China)

Jaime Rodríguez of Olivares explains the implications of the revocation by the Mexican Federal Court of Administrative Affairs of the criteria commonly used to allow complainants to credit their legal standing on trademark non-use cancellation proceedings

Mariana Patiño of Olivares discusses the EU Intellectual Property Office (EUIPO) guidelines on the protection of intangible assets in the metaverse

Peter Blasi, Global Strategic Account Manager for the CAS Ionic Affinity Program, talks to Managing IP about prior art patent searches, sharing his advice on maximising both thoroughness and efficiency

CAS explains how intellectual property (IP) is becoming increasingly central to companies, particularly to research and development (R&D) teams, and highlights five key findings from a survey of senior business leaders

CAS explains the five high-risk areas of IP for R&D organisations and identifies how companies can protect their innovations and safeguard their growth potential